QUAY STEVEN C 4
4 · ATOSSA THERAPEUTICS, INC. · Filed Mar 6, 2023
Insider Transaction Report
Form 4
QUAY STEVEN C
DirectorPresident & CEO
Transactions
- Award
Stock Option (right to buy)
2023-03-02+1,873,100→ 1,873,100 totalExercise: $0.72Exp: 2033-03-02→ Common Stock (1,873,100 underlying)
Footnotes (1)
- [F1]The option will vest and become exercisable on a quarterly basis over 24 months from the grant-date.